Statins
Date Range
Score Range
Statins framed as ineffective for metabolically healthy individuals
Cherry-picked evidence is used to suggest statins offer minimal benefit to healthy people, while omitting broader data on their proven cardiovascular protection in primary prevention.
“Individuals who are metabolically healthier – those with lower triglycerides, higher HDL (“good cholesterol”), lower blood pressure and fewer features of metabolic syndrome – tend to derive minimal, if any, cardiovascular benefit from statins.”
Statins portrayed as posing hidden health risks
The article emphasizes potential harms of statins (e.g., diabetes, muscle loss, reduced GLP-1) without balancing them with population-level benefits, using vague attribution and emotionally charged language.
“He cites research suggesting that statins can lead to reductions in GLP-1 levels – working the opposite way to drugs such as Wegovy and Ozempic, increasing appetite and leading to weight gain.”